Regulatory considerations for preclinical development of anticancer drugs
Gespeichert in:
| Veröffentlicht in: | Cancer chemotherapy and pharmacology 1997-12, Vol.41 (3), p.173-185 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 185 |
|---|---|
| container_issue | 3 |
| container_start_page | 173 |
| container_title | Cancer chemotherapy and pharmacology |
| container_volume | 41 |
| creator | DeGeorge, Joseph J. Ahn, Chang-Ho Andrews, Paul A. Brower, Margaret E. Giorgio, Diana W. Goheer, M. Anwar Lee-Ham, Doo Y. McGuinn, W. David Schmidt, Wendelyn Sun, C. Joseph Tripathi, Satish C. |
| description | |
| doi_str_mv | 10.1007/s002800050726 |
| format | Article |
| fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1007_s002800050726</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1007_s002800050726</sourcerecordid><originalsourceid>FETCH-LOGICAL-c152t-2022a871d88e42ead0fd8b3b434b612e4256292a0772bb09d50ca55fe828dd823</originalsourceid><addsrcrecordid>eNpVkE1LxDAURYMoWEeX7vMHoi8vSZtZyuDHwIAgui5p8jJUOk1JOsL8eyu6cXUvh8tdHMZuJdxJgOa-AKAFAAMN1mesklqhAKvVOatAaS1MA_qSXZXyuay0VKpi2zfaHwc3p3ziPo2lD5Td3C-Nx5T5lMkP_dh7N_BAXzSk6UDjzFPkbpwXPHrKPOTjvlyzi-iGQjd_uWIfT4_vmxexe33ebh52wkuDs0BAdLaRwVrSSC5ADLZTnVa6qyUuzNS4RgdNg10H62DAO2MiWbQhWFQrJn5_fU6lZIrtlPuDy6dWQvvjof3nQX0DNeFQtw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Regulatory considerations for preclinical development of anticancer drugs</title><source>SpringerNature Journals</source><creator>DeGeorge, Joseph J. ; Ahn, Chang-Ho ; Andrews, Paul A. ; Brower, Margaret E. ; Giorgio, Diana W. ; Goheer, M. Anwar ; Lee-Ham, Doo Y. ; McGuinn, W. David ; Schmidt, Wendelyn ; Sun, C. Joseph ; Tripathi, Satish C.</creator><creatorcontrib>DeGeorge, Joseph J. ; Ahn, Chang-Ho ; Andrews, Paul A. ; Brower, Margaret E. ; Giorgio, Diana W. ; Goheer, M. Anwar ; Lee-Ham, Doo Y. ; McGuinn, W. David ; Schmidt, Wendelyn ; Sun, C. Joseph ; Tripathi, Satish C.</creatorcontrib><identifier>ISSN: 0344-5704</identifier><identifier>EISSN: 1432-0843</identifier><identifier>DOI: 10.1007/s002800050726</identifier><language>eng</language><ispartof>Cancer chemotherapy and pharmacology, 1997-12, Vol.41 (3), p.173-185</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c152t-2022a871d88e42ead0fd8b3b434b612e4256292a0772bb09d50ca55fe828dd823</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>DeGeorge, Joseph J.</creatorcontrib><creatorcontrib>Ahn, Chang-Ho</creatorcontrib><creatorcontrib>Andrews, Paul A.</creatorcontrib><creatorcontrib>Brower, Margaret E.</creatorcontrib><creatorcontrib>Giorgio, Diana W.</creatorcontrib><creatorcontrib>Goheer, M. Anwar</creatorcontrib><creatorcontrib>Lee-Ham, Doo Y.</creatorcontrib><creatorcontrib>McGuinn, W. David</creatorcontrib><creatorcontrib>Schmidt, Wendelyn</creatorcontrib><creatorcontrib>Sun, C. Joseph</creatorcontrib><creatorcontrib>Tripathi, Satish C.</creatorcontrib><title>Regulatory considerations for preclinical development of anticancer drugs</title><title>Cancer chemotherapy and pharmacology</title><issn>0344-5704</issn><issn>1432-0843</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LxDAURYMoWEeX7vMHoi8vSZtZyuDHwIAgui5p8jJUOk1JOsL8eyu6cXUvh8tdHMZuJdxJgOa-AKAFAAMN1mesklqhAKvVOatAaS1MA_qSXZXyuay0VKpi2zfaHwc3p3ziPo2lD5Td3C-Nx5T5lMkP_dh7N_BAXzSk6UDjzFPkbpwXPHrKPOTjvlyzi-iGQjd_uWIfT4_vmxexe33ebh52wkuDs0BAdLaRwVrSSC5ADLZTnVa6qyUuzNS4RgdNg10H62DAO2MiWbQhWFQrJn5_fU6lZIrtlPuDy6dWQvvjof3nQX0DNeFQtw</recordid><startdate>19971209</startdate><enddate>19971209</enddate><creator>DeGeorge, Joseph J.</creator><creator>Ahn, Chang-Ho</creator><creator>Andrews, Paul A.</creator><creator>Brower, Margaret E.</creator><creator>Giorgio, Diana W.</creator><creator>Goheer, M. Anwar</creator><creator>Lee-Ham, Doo Y.</creator><creator>McGuinn, W. David</creator><creator>Schmidt, Wendelyn</creator><creator>Sun, C. Joseph</creator><creator>Tripathi, Satish C.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>19971209</creationdate><title>Regulatory considerations for preclinical development of anticancer drugs</title><author>DeGeorge, Joseph J. ; Ahn, Chang-Ho ; Andrews, Paul A. ; Brower, Margaret E. ; Giorgio, Diana W. ; Goheer, M. Anwar ; Lee-Ham, Doo Y. ; McGuinn, W. David ; Schmidt, Wendelyn ; Sun, C. Joseph ; Tripathi, Satish C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c152t-2022a871d88e42ead0fd8b3b434b612e4256292a0772bb09d50ca55fe828dd823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>DeGeorge, Joseph J.</creatorcontrib><creatorcontrib>Ahn, Chang-Ho</creatorcontrib><creatorcontrib>Andrews, Paul A.</creatorcontrib><creatorcontrib>Brower, Margaret E.</creatorcontrib><creatorcontrib>Giorgio, Diana W.</creatorcontrib><creatorcontrib>Goheer, M. Anwar</creatorcontrib><creatorcontrib>Lee-Ham, Doo Y.</creatorcontrib><creatorcontrib>McGuinn, W. David</creatorcontrib><creatorcontrib>Schmidt, Wendelyn</creatorcontrib><creatorcontrib>Sun, C. Joseph</creatorcontrib><creatorcontrib>Tripathi, Satish C.</creatorcontrib><collection>CrossRef</collection><jtitle>Cancer chemotherapy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>DeGeorge, Joseph J.</au><au>Ahn, Chang-Ho</au><au>Andrews, Paul A.</au><au>Brower, Margaret E.</au><au>Giorgio, Diana W.</au><au>Goheer, M. Anwar</au><au>Lee-Ham, Doo Y.</au><au>McGuinn, W. David</au><au>Schmidt, Wendelyn</au><au>Sun, C. Joseph</au><au>Tripathi, Satish C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Regulatory considerations for preclinical development of anticancer drugs</atitle><jtitle>Cancer chemotherapy and pharmacology</jtitle><date>1997-12-09</date><risdate>1997</risdate><volume>41</volume><issue>3</issue><spage>173</spage><epage>185</epage><pages>173-185</pages><issn>0344-5704</issn><eissn>1432-0843</eissn><doi>10.1007/s002800050726</doi><tpages>13</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0344-5704 |
| ispartof | Cancer chemotherapy and pharmacology, 1997-12, Vol.41 (3), p.173-185 |
| issn | 0344-5704 1432-0843 |
| language | eng |
| recordid | cdi_crossref_primary_10_1007_s002800050726 |
| source | SpringerNature Journals |
| title | Regulatory considerations for preclinical development of anticancer drugs |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T20%3A37%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Regulatory%20considerations%20for%20preclinical%20development%20of%20anticancer%20drugs&rft.jtitle=Cancer%20chemotherapy%20and%20pharmacology&rft.au=DeGeorge,%20Joseph%20J.&rft.date=1997-12-09&rft.volume=41&rft.issue=3&rft.spage=173&rft.epage=185&rft.pages=173-185&rft.issn=0344-5704&rft.eissn=1432-0843&rft_id=info:doi/10.1007/s002800050726&rft_dat=%3Ccrossref%3E10_1007_s002800050726%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |